It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pigs are important experimental animals for cardiovascular research. Few porcine coronary atherosclerosis models have been developed; however, their induction requires more than six months. We developed a porcine coronary artery atherosclerosis model using nicotine injection with a balloon overdilation. A coronary balloon was placed in the porcine coronary artery and overdilated to induce a mechanical injury. Nicotine was administrated via intramuscular injection every day, and changes in the coronary artery were observed after four weeks. Coronary angiography revealed nicotine injection with a balloon overdilation group showed narrowing of the coronary artery at the injury site. The combination of balloon and nicotine significantly increased the intimal hyperplasia in optical coherence tomography analysis. Proliferated tunica media were noted in the nicotine injection with balloon overdilation groups and lack of collagen was observed in the tunica media at eight weeks. Quantitative analysis showed increased smooth muscle actin alpha (SMA), cluster of differentiation 68 (CD68), and Krüppel-like factor 4 (KLF4) in the nicotine injection with balloon overdilation groups. Immunohistochemistry results showed CD68-positive cells displayed SMA- and KLF4-positive reactivity in the border zone of the intimal hyperplasia. Our results show that nicotine injection with balloon overdilation can induce atherosclerotic lesions within one month, which can serve as an alternative pig animal model for the development of coronary stents.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 National University Hospital Designated by Korea Ministry of Health and Welfare, The Cardiovascular Convergence Research Center of Chonnam, Gwangju, Republic of Korea (GRID:grid.452940.e) (ISNI:0000 0004 0647 2447)
2 National University Hospital Designated by Korea Ministry of Health and Welfare, The Cardiovascular Convergence Research Center of Chonnam, Gwangju, Republic of Korea (GRID:grid.452940.e) (ISNI:0000 0004 0647 2447); Korea Cardiovascular Stent Research Institute, Jangsung, Republic of Korea (GRID:grid.496081.2)
3 National University Hospital, Cardiovascular Convergence Research Center Nominated By Korea Ministry of Health and Welfare, Division of Cardiology of Chonnam, Gwangju, Republic of Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X)
4 National University Hospital Designated by Korea Ministry of Health and Welfare, The Cardiovascular Convergence Research Center of Chonnam, Gwangju, Republic of Korea (GRID:grid.452940.e) (ISNI:0000 0004 0647 2447); Korea Cardiovascular Stent Research Institute, Jangsung, Republic of Korea (GRID:grid.496081.2); National University Hospital, Cardiovascular Convergence Research Center Nominated By Korea Ministry of Health and Welfare, Division of Cardiology of Chonnam, Gwangju, Republic of Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X)